LONDON, United Kingdom (AFP) - Clinical trials on one of the most advanced experimental novel coronavirus vaccines, which is being developed by pharmaceutical company AstraZeneca and University of Oxford, were 'paused' Tuesday after a volunteer developed an unexplained illness.
